Gerresheimer Business Model Robust

Author's Avatar
Apr 09, 2020
Article's Main Image

- Stable business model as key supplier to pharma and healthcare industry

- Gerresheimer sustains growth path. Revenue guidance for 2020 in the mid single-digit percentage range and adjusted EBITDA margin of around 21% confirmed

- Refinancing of EUR 190m promissory loan maturing in November 2020 secured ahead of time

- First quarter level with prior year, as expected: revenues EUR 304m, adjusted EBITDA EUR 51m

PR Newswire